全文获取类型
收费全文 | 388735篇 |
免费 | 26651篇 |
国内免费 | 9100篇 |
专业分类
耳鼻咽喉 | 4982篇 |
儿科学 | 10231篇 |
妇产科学 | 6959篇 |
基础医学 | 31724篇 |
口腔科学 | 9316篇 |
临床医学 | 42162篇 |
内科学 | 47955篇 |
皮肤病学 | 5214篇 |
神经病学 | 21482篇 |
特种医学 | 9594篇 |
外国民族医学 | 35篇 |
外科学 | 44834篇 |
综合类 | 59281篇 |
现状与发展 | 18篇 |
一般理论 | 33篇 |
预防医学 | 38472篇 |
眼科学 | 6242篇 |
药学 | 34343篇 |
454篇 | |
中国医学 | 35097篇 |
肿瘤学 | 16058篇 |
出版年
2023年 | 6224篇 |
2022年 | 11144篇 |
2021年 | 14948篇 |
2020年 | 14244篇 |
2019年 | 19788篇 |
2018年 | 17292篇 |
2017年 | 14454篇 |
2016年 | 12011篇 |
2015年 | 11286篇 |
2014年 | 22904篇 |
2013年 | 24619篇 |
2012年 | 21025篇 |
2011年 | 23132篇 |
2010年 | 19056篇 |
2009年 | 17139篇 |
2008年 | 16495篇 |
2007年 | 17000篇 |
2006年 | 14960篇 |
2005年 | 13017篇 |
2004年 | 10612篇 |
2003年 | 9336篇 |
2002年 | 7362篇 |
2001年 | 6640篇 |
2000年 | 5499篇 |
1999年 | 4753篇 |
1998年 | 3911篇 |
1997年 | 3727篇 |
1996年 | 3191篇 |
1995年 | 3006篇 |
1994年 | 2891篇 |
1993年 | 2259篇 |
1992年 | 2276篇 |
1991年 | 1963篇 |
1990年 | 1744篇 |
1989年 | 1532篇 |
1988年 | 1443篇 |
1987年 | 1222篇 |
1985年 | 3938篇 |
1984年 | 4937篇 |
1983年 | 3430篇 |
1982年 | 3930篇 |
1981年 | 3667篇 |
1980年 | 3268篇 |
1979年 | 2990篇 |
1978年 | 2611篇 |
1977年 | 1964篇 |
1976年 | 2206篇 |
1975年 | 1670篇 |
1974年 | 1454篇 |
1973年 | 1297篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
《Vaccine》2020,38(45):7118-7128
IntroductionToward the Global Vaccine Action Plan 2020 goal, almost 90% of countries have established a National Immunization Technical Advisory Group (NITAG). However, little is known about NITAG's contributions to governance.MethodsIn 2017–2018, a two-step, qualitative retrospective study was conducted. Jordan (JO), Argentina (AR), and South Africa (SA) were selected owing to government-financed NITAGs from middle-income countries (MICs), geographic diversity, and a vaccine introduction with NITAG support. Country case studies were developed, collecting data through desk review and face-to-face key informant interviews (KIIs) from Ministry of Health (MoH) and NITAG. Case studies were analyzed together, to assess governance applying the European Observatory on Health Systems and Policies framework focusing on transparency, accountability, participation, integrity, and policy capacity (TAPIC).ResultsDocument review and 53 KII (22 AR, 20 SA, 11 JO) showed NITAGs played a pivotal role as advisors promoting a culture of evidence-informed policies. NITAGs strengthened governance, although practices varied among countries. Meetings were conducted behind-closed-doors, participation restricted to members, only in one country agendas, and recommendations were public (AR). To increase participation, policy capacity, and transparency, countries considered adding experts in communications, advocacy, and economics. AR and SA contemplated including community members. NITAGs functioned autonomously from the government, with no established internal or external monitoring or supervision. NITAG meeting minutes allowed the review of integrity, adherence to terms of reference, standard operating procedures, and conflict of interest (CoI). For the most part, NITAGs abided by their mandates. Significant issues were related to the level of MoH support and oversight of CoI declaration and documentation.ConclusionsSystematically implementing governance approaches could improve processes, better tailor policies, and implementation. The long-term survival and resilience of NITAGs in these countries showed they play a significant role in strengthening governance. Lessons learned could be useful to those promoting country-driven evidence-informed decision-making. 相似文献
82.
83.
84.
85.
《Journal of vascular and interventional radiology : JVIR》2020,31(6):869-875
This paper describes country-wide special measures undertaken for interventional radiology staff during the current coronavirus disease 2019 (COVID-19) pandemic. Although each interventional radiology service around the world faces unique challenges, the principles outlined in this article will be useful when designing or strengthening individual practices and integrating them within wider hospital and national measures. Moving beyond the current outbreak, these measures will be useful for any future infectious diseases which are likely to arise. 相似文献
86.
87.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献88.
89.
90.
当代社会,老年人口比例呈现不断上升的趋势,老龄化问题日益严峻。因此,如何有效地延缓衰老不仅成为了世界医学研究的热点,也成为了全球亟待解决的问题。中医药在延缓衰老方面经验丰富,而滋阴药在此类研究中效果显著。本文通过整理滋阴药抗衰老作用机制的若干文献,对滋阴复方六味地黄丸、二至丸、左归丸及其他滋阴中药延缓衰老的机制研究进展进行综述。 相似文献